Vapourizer demand expected to grow to $45 billion

Published on April 1, 2022 by oz. staff

Photo: Contributed
A Volcano from Storz & Bickel, owned by Canopy Growth

The demand for vaporizers grew substantially during the COVID-19 pandemic—and it’s expected to continue to grow, according to a new report.

Research by says the global vaporizers market is expected to grow from just over $13 billion in 2021 to more than $17 billion in 2022. At this pace, the market is expected to reach nearly $45 billion in 2026.

“Growing advancements in vaporizers are driving the growth of the vaporizers market,” says the market research company.

Reportlinker says companies have now stabilized their output after skyrocketing demand.

The report looked at cannabis vapourizers (both dry-herb and concerntrate), as well as e-cigarette and medical vapes.

“Medicated cannabis vaporizers have gained increasing demand in the vaporizers market,” says the report. “Cannabis vaporizers have controlling heating technology and offer the possibility of precisely adjusting the temperature of the heater using a display on the unit, giving the user full control over the density of the aerosol produced.”

Storz & Bickel, for example, has a line of popular vapourizers, including The Mighty and the Volcano.

The 250-page report looked at Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Major players in the vaporizers market are Vicks, Vanker, Grizzly Guru, FGB Natural Products, GE Healthcare, Penlon Ltd, Draegerwerk AG & Co. KGaA, Rothacher Medical GmbH, Allied Medical Ltd, and Intersurgical Ltd.

Here’s a link to the report’s summary.